Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
BOT Botanix Pharmaceuticals Ltd
- 0.420
- +0.025+6.33%
20min DelayMarket Closed Dec 27 16:00 AET
763.40MMarket Cap-46.67P/E (Static)
0.425High0.390Low6.98MVolume0.390Open0.395Pre Close2.88MTurnover0.44552wk High0.44%Turnover Ratio1.82BShares0.16052wk Low-0.009EPS TTM665.16MFloat Cap3359.997Historical HighLossP/E (Static)1.58BShs Float0.013Historical Low-0.009EPS LYR8.86%Amplitude--Dividend TTM7.00P/B1Lot Size--Div YieldTTM
About Botanix Pharmaceuticals Ltd Company
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.
Company Profile
SymbolBOT
Company NameBotanix Pharmaceuticals Ltd
Founded1984
MarketASX
Employees3
Fiscal Year Ends06-30
Address41 - 47 Colin Street Suite 3
CityWest Perth
CountryAustralia
Zip Code6005
Phone+61 865552945
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Vince Ippolito
- President,Executive Chairman,Executive Director
- --
- Stewart James Washer
- Non-Executive Director
- --
- Matthew (Matt) Callahan
- Executive Director
- --
- H. William Bosch
- Executive Director
- --
- Daniel Sharp
- Non-Executive Director
- --